5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.71▼ | 1.71▼ | 1.72▼ | 1.79▼ | 1.91▼ |
MA10 | 1.71▼ | 1.72▼ | 1.73▼ | 1.96▼ | 2.00▼ |
MA20 | 1.72▼ | 1.74▼ | 1.76▼ | 2.01▼ | 2.15▼ |
MA50 | 1.73▼ | 1.78▼ | 1.89▼ | 2.02▼ | 2.81▼ |
MA100 | 1.77▼ | 1.93▼ | 2.03▼ | 2.17▼ | 3.86▼ |
MA200 | 1.85▼ | 2.03▼ | 2.00▼ | 2.66▼ | 5.68▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.001▲ | 0.004▲ | -0.047▼ | 0.025▲ |
RSI | 38.915▼ | 34.929▼ | 30.967▼ | 38.088▼ | 37.387▼ |
STOCH | 33.333 | 16.768▼ | 15.513▼ | 6.937▼ | 31.981 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -83.333▼ |
CCI | -86.583 | -120.332▼ | -117.247▼ | -129.464▼ | -97.280 |
Friday, April 19, 2024 03:00 AM
Emeren Group Ltd ("Emeren" or the "Company") ( (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced that on April 17, 2024, it received a notice from the New ...
|
Thursday, April 18, 2024 04:27 AM
About AXPAXLI™ AXPAXLI is an investigational bioresorbable, hydrogel implant incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic properties, being ...
|
Wednesday, April 17, 2024 07:33 AM
Texas Pacific Land Corp. operates as a landowner in the State of Texas. Its surface and royalty ownership allow revenue generation through the entire value chain of oil and gas development ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/04/24 | 1.755 | 1.765 | 1.70 | 1.70 | 339,587 |
18/04/24 | 1.80 | 1.81 | 1.715 | 1.74 | 407,450 |
17/04/24 | 1.85 | 1.895 | 1.77 | 1.78 | 283,553 |
16/04/24 | 1.85 | 1.8518 | 1.795 | 1.85 | 316,779 |
15/04/24 | 2.03 | 2.04 | 1.85 | 1.86 | 386,282 |
12/04/24 | 2.16 | 2.185 | 1.99 | 2.01 | 377,641 |
11/04/24 | 2.11 | 2.19 | 2.08 | 2.18 | 349,103 |
10/04/24 | 2.15 | 2.15 | 2.04 | 2.14 | 438,486 |
09/04/24 | 2.15 | 2.28 | 2.14 | 2.20 | 333,306 |
08/04/24 | 2.04 | 2.17 | 2.04 | 2.15 | 298,832 |
|
|
||||
|
|
||||
|
|